| Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer M Xing, AS Alzahrani, KA Carson, D Viola, R Elisei, B Bendlova, L Yip, ... Jama 309 (14), 1493-1501, 2013 | 1036 | 2013 |
| Association between BRAF V600E mutation and recurrence of papillary thyroid cancer M Xing, AS Alzahrani, KA Carson, YK Shong, TY Kim, D Viola, R Elisei, ... Journal of clinical oncology 33 (1), 42, 2015 | 598 | 2015 |
| Androgen receptor mutations in prostate cancer M Marcelli, M Ittmann, S Mariani, R Sutherland, R Nigam, L Murthy, ... Cancer research 60 (4), 944-949, 2000 | 512 | 2000 |
| The natural history of benign thyroid nodules C Durante, G Costante, G Lucisano, R Bruno, D Meringolo, A Paciaroni, ... Jama 313 (9), 926-935, 2015 | 489 | 2015 |
| BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism C Durante, E Puxeddu, E Ferretti, R Morisi, S Moretti, R Bruno, F Barbi, ... The Journal of Clinical Endocrinology & Metabolism 92 (7), 2840-2843, 2007 | 453 | 2007 |
| BRAFV599E Mutation Is the Leading Genetic Event in Adult Sporadic Papillary Thyroid Carcinomas E Puxeddu, S Moretti, R Elisei, C Romei, R Pascucci, M Martinelli, ... The Journal of Clinical Endocrinology & Metabolism 89 (5), 2414-2420, 2004 | 348 | 2004 |
| Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum A Sarkozy, C Carta, S Moretti, G Zampino, MC Digilio, F Pantaleoni, ... Human mutation 30 (4), 695-702, 2009 | 338 | 2009 |
| Correlation between B-RAFV600E mutation and clinico–pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature L Fugazzola, E Puxeddu, N Avenia, C Romei, V Cirello, A Cavaliere, ... Endocrine-related cancer 13 (2), 455-464, 2006 | 289 | 2006 |
| Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants X Shi, R Liu, F Basolo, R Giannini, X Shen, D Teng, H Guan, Z Shan, ... The Journal of Clinical Endocrinology 101 (1), 264-274, 2016 | 233 | 2016 |
| B-RafV600E and thrombospondin-1 promote thyroid cancer progression C Nucera, A Porrello, ZA Antonello, M Mekel, MA Nehs, TJ Giordano, ... Proceedings of the National Academy of Sciences 107 (23), 10649-10654, 2010 | 202 | 2010 |
| Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: biodistribution, pharmacokinetic features and in vivo antitumor activity D Paolino, D Cosco, L Racanicchi, E Trapasso, C Celia, M Iannone, ... Journal of Controlled Release 144 (2), 144-150, 2010 | 146 | 2010 |
| of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO# 2) L Lamartina, G Grani, E Arvat, A Nervo, MC Zatelli, R Rossi, E Puxeddu, ... Endocrine-Related Cancer 25 (3), L7-L11, 2018 | 136 | 2018 |
| Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes C Romei, S Mariotti, L Fugazzola, A Taccaliti, F Pacini, G Opocher, C Mian, ... European Journal of Endocrinology 163 (2), 301-308, 2010 | 130 | 2010 |
| Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study F Calzolari, PV Sartori, C Talarico, D Parmeggiani, E Beretta, L Pezzullo, ... Anticancer research 28 (5B), 2885-2888, 2008 | 125 | 2008 |
| Modifications in the papillary thyroid cancer gene profile over the last 15 years C Romei, L Fugazzola, E Puxeddu, F Frasca, D Viola, M Muzza, S Moretti, ... The Journal of Clinical Endocrinology & Metabolism 97 (9), E1758-E1765, 2012 | 124 | 2012 |
| Epigenetics of thyroid cancer and novel therapeutic targets. D Russo, G Damante, E Puxeddu, C Durante, S Filetti Journal of Molecular Endocrinology 46 (3), R73-81, 2011 | 109 | 2011 |
| Patient age–associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer X Shen, G Zhu, R Liu, D Viola, R Elisei, E Puxeddu, L Fugazzola, ... Journal of Clinical Oncology 36 (5), 438, 2018 | 106 | 2018 |
| Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new … C Carta, S Moretti, L Passeri, F Barbi, N Avenia, A Cavaliere, M Monacelli, ... Clinical endocrinology 64 (1), 105-109, 2006 | 104 | 2006 |
| RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response E Puxeddu, JA Knauf, MA Sartor, N Mitsutake, EP Smith, M Medvedovic, ... Endocrine-Related Cancer 12 (2), 319-334, 2005 | 104 | 2005 |
| Clinical implications of BRAF mutation in thyroid carcinoma E Puxeddu, C Durante, N Avenia, S Filetti, D Russo Trends in Endocrinology & Metabolism 19 (4), 138-145, 2008 | 103 | 2008 |
